Clinical Trials List
2020-10-26 - 2029-12-31
Phase III
Not yet recruiting6
Recruiting1
ICD-10C16.9
Malignant neoplasm of stomach, unspecified
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.9
Malignant neoplasm of stomach, unspecified
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/23
Investigators and Locations
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
- Chung-Pin Li Digestive System Department
- Rheun-Chuan Lee 未分科
- San-Chi Chen Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- Yun-Cheng Hsieh 未分科
- 方文良 Division of General Surgery
- 黃國宏 Division of General Surgery
- Shao-Jung Hsu Digestive System Department
- Chien-An Liu
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsai-Sheng Yang 未分科
- Wen-Chi Chou Division of Hematology & Oncology
- Hung-Chih Hsu 未分科
- Wen-Chi Shen Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Ming-Mo Hou Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- Tai-Sen Yeh Division of General Surgery
- Chun-Nan Yeh Division of General Surgery
- 徐潤德 Division of General Surgery
- 劉耿豪 Division of General Surgery
- 李兆偉 Division of General Surgery
- 蔡駿逸 Division of General Surgery
- 曾振輝 Division of Radiology
- 吳仁欽 未分科
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 趙盈瑞 Division of General Surgery
- 劉奕廷 Division of Hematology & Oncology
- Chia-Jui Yen 未分科
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 楊宏仁 Division of General Surgery
- 陳德鴻 Division of General Surgery
- Chang-Fang Chiu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Ann-Lii Cheng 未分科
- Chih-Hung Hsu 未分科
- Chiun Hsu Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- Hsiang-Fong Kao 未分科
- 郭弘揚 Division of Hematology & Oncology
- TSUNG-HAO LIU Division of General Surgery
- I-RUE LAI Division of General Surgery
- 陳炯年 Division of General Surgery
- 李柏居 Division of General Surgery
- 楊博仁 Division of General Surgery
- MING-TSAN LIN Division of Hematology & Oncology
- Ying-Chun Shen Division of Others -
- 蔡佳惠
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
42 participants
-
Global
900 participants
